Bandingkan Harga & Kinerja Cita Mineral Investindo Tbk. (CITA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Cita Mineral Investindo Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Cita Mineral Investindo Tbk. diperdagangkan di Rp3.200 (kapitalisasi pasar 12,67 T, volume 24 jam 50,9 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 164,65 M, volume 24 jam 43,9 rb). Perbedaan utamanya: Cita Mineral Investindo Tbk. jauh lebih besar — sekitar 77× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Cita Mineral Investindo Tbk. lebih aktif diperdagangkan (50,9 rb vs 43,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CITA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 12,67 T | 164,65 M |
Volume | 50,9 rb | 43,9 rb |
Lot | 509 | 439 |
Perputaran | 161,98 jt | 10,6 jt |
Harga Rata-rata | 3.182,26 | 241,43 |
Nilai Transaksi | 161,98 jt | 10,6 jt |
Harga Ekuilibrium Indikatif | — | 238 |
Volume Ekuilibrium Indikatif | — | 100 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Cita Mineral Investindo Tbk.
PT Cita Mineral Investindo Tbk based in Tanggerang established formerly under the name PT. Cipta Panelutama on June 27th 1992. Conduct in furniture manufacturing industry both production & marketing. Start the business in furniture panel production which made by particle board & medium density fibreboard to export to Euro and Arabic market. Type of product such as TV, Audio-Video Cable Cabinet, CD Holder, Computer Workstation & Home Entertainment Center.
Selengkapnya di halaman CITA →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
